search
Back to results

Exercise to Manage Fatigue in Progressive Multiple Sclerosis

Primary Purpose

Multiple Sclerosis

Status
Unknown status
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Tailored exercise intervention
Standard exercise intervention
Sponsored by
Glasgow Caledonian University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Multiple Sclerosis focused on measuring Multiple Sclerosis, Exercise, Fatigue

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Neurologist-confirmed diagnosis of MS and a progressive form of the disease (either secondary or primary progressive)
  • Self-report of moderate-severe fatigue in the last 7 days at screening by indicating that their fatigue is six or more when answering the following "have you had fatigue in the last seven days: between 0 (no fatigue) and 10 (extremely fatigued).
  • Moderate level of disability to allow for participants to use the bicycle ergometer (indicated by an Expanded Disability Status Scale score of between ≥4 and ≤6.5)
  • Be willing and able to attend Falkirk Community Hospital, twice a week for 8 consecutive weeks to receive the intervention.

Exclusion Criteria:

  • A neurologist confirmed relapse of MS within the past three months
  • Commenced or had a change in MS disease modifying treatment within the past six months
  • Unable to provide informed consent
  • Concurrently participating in another intervention trial
  • Diagnosed with any of the following conditions which may also cause high levels of fatigue: anaemia, inflammatory rheumatic disease, hypothyroidism, cancer
  • Cardiovascular event in the past year including but not limited to: myocardial infarction, transient ischaemic attack or cerebrovascular accident
  • Diagnosis of cardiovascular, respiratory, or metabolic disease that would prevent participants from safely performing exercise including but not limited to: angina, heart failure, uncontrolled hypertension, peripheral vascular disease, chronic obstructive pulmonary disease, diabetes mellitus
  • Prescription of the following medication: beta blockers, vasodilators, ACE inhibitors, diuretics or any other medication that may cause exercise induced hypotension
  • Significant co-morbidity such as significant musculoskeletal or neurological conditions other than MS

Sites / Locations

  • Falkirk Community HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Active Comparator

No Intervention

Arm Label

Tailored exercise intervention

Standard exercise intervention

Usual care control

Arm Description

8 weeks of aerobic interval training at moderate intensity which is modified according to the levels of self-reported fatigue

8 weeks of aerobic interval training at a moderate intensity

Participants in the usual care control group will continue to receive their standard care independent of this study

Outcomes

Primary Outcome Measures

Intervention tolerance
Participants will record the severity of fatigue before and for 48-hours following each exercise session using a Numerical Rating Scale
Intervention adherence
Adherence will be determined by recording the proportion of exercise sessions that each participant attends, whether the participant completes the prescribed exercise duration during each session, and whether the participant is able to reach and maintain the prescribed target heart rate
Intervention acceptability
The participants' views of the study procedures will be explored using an online survey. The survey contains questions relating to the content of the exercise/control groups, relevance of outcome measures included, the perceived positive/negatives of the intervention, and ways to improve the study design

Secondary Outcome Measures

Fatigue Severity Scale
Self-reported questionnaire measuring the severity of fatigue
Modified Fatigue Impact Scale
Self-reported questionnaire measuring the impact of fatigue on physical, cognitive, and psychosocial function
Aerobic capacity
Aerobic capacity estimated using the YMCA sub-maximal bicycle ergometer test
Multiple Sclerosis Impact Scale
Self-reported questionnaire measuring the physical and psychological impact of Multiple Sclerosis
Hospital Anxiety and Depression Scale
Self-reported questionnaire measuring the severity of anxiety and depression
Pittsburgh Sleep Quality Index
Self-reported questionnaire measuring sleep quality
Symbol Digits Modalities Test
Cognitive screening tool which measures processing speed
Six Minute Walk Test
Measurement of the maximum walking distance covered during 6 minutes
Energy Cost of Walking
Estimation of oxygen consumption per meter walked during the six minute walk test measured using Cosmed K4 portable oxygen telemetry system

Full Information

First Posted
March 9, 2020
Last Updated
March 11, 2020
Sponsor
Glasgow Caledonian University
search

1. Study Identification

Unique Protocol Identification Number
NCT04304027
Brief Title
Exercise to Manage Fatigue in Progressive Multiple Sclerosis
Official Title
Feasibility Evaluation of a Tailored Exercise Intervention to Manage Fatigue in Progressive Multiple Sclerosis
Study Type
Interventional

2. Study Status

Record Verification Date
January 2020
Overall Recruitment Status
Unknown status
Study Start Date
December 10, 2019 (Actual)
Primary Completion Date
June 2020 (Anticipated)
Study Completion Date
June 2020 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Glasgow Caledonian University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Fatigue is one of the most common and debilitating symptoms of Multiple Sclerosis (MS). Exercise is suggested as a way to improve fatigue, but it is not clear what the effects of exercise are on fatigue - especially in people with progressive MS. Therefore, this study aims to test the feasibility of a tailored exercise programme to help improve fatigue in people with progressive MS. To do this people with progressive MS who are experiencing fatigue will be randomly allocated to receive either a tailored exercise programme, a standard exercise programme, or their usual care. Both exercise programmes will be 8 weeks long and require participants to attend Falkirk Community Hospital twice a week. The standard exercise programme involves a moderate intensity interval training session using a stationary exercise bike. The tailored exercise programme is similar to the standard exercise programme, as participants will be prescribed the same type and duration of exercise; however, the difference between the 2 programmes is that the intensity of exercise performed during each session of the tailored exercise programme is dictated by the participant's level of fatigue. Participants will complete an exercise test, walking test, and questionnaires relating to fatigue, quality of life, depression and anxiety, sleep quality, and cognition before and 1 week after completing the exercise programme.
Detailed Description
This study aims to evaluate the feasibility of delivering a tailored exercise intervention to manage fatigue in people with progressive forms of MS. To do this, a randomised controlled trial design will be used to assess the feasibility of delivering a tailored exercise intervention to manage fatigue in people with progressive forms of MS in comparison to a standard (untailored) exercise group and usual care control group. This study aims to recruit up to 45 people with progressive MS who are experiencing moderate-severe levels of fatigue from MS clinics and outpatient physiotherapy services within NHS Forth Valley. Participants will be randomly allocated to receive either the tailored exercise programme, the standard exercise programme, or their usual care. All outcome measures will be recorded at baseline and post-intervention. Both exercise programmes will require participants to attend Falkirk Community Hospital twice a week for 8 weeks - therefore, participants will receive 16 exercise sessions in total. All exercise sessions will be supervised by a physiotherapist and they will provide participants with any support that is required. The standard exercise programme involves aerobic-based interval training delivered on a bicycle ergometer. Each exercise session will be 30 minutes in duration, and will be broken down into a 3 minute warm-up, 24 minutes of interval training, and a 3 minute cool-down. During the interval training component, participants will be asked to perform 6 intervals that require them to exercise at a moderate intensity (>70% heart rate reserve) for 2 minutes followed by 2 minutes of recovery. The tailored exercise programme is similar to the standard exercise programme - participants will still be required to attend Falkirk Community Hospital twice a week for 8 weeks, and they will perform the same type and duration of exercise as the standard exercise programme. However in order to tailor exercise to fatigue, participants will be asked to rate their current levels of fatigue before exercising - this rating will then be compared to the baseline score. If the participant's fatigue is worse, they will be offered the option of performing a lower intensity of exercise for that specific session (>50% heart rate reserve). In addition, participants will also be asked to monitor their fatigue in a symptom diary for 2 days following each exercise session. If fatigue is worsened by exercise and remains elevated for 2 days after 2 consecutive exercise sessions, then they will also be offered the option of performing the lower intensity exercise prescription. Participants in the usual care control group will continue to receive their standard care independent of this study. Participants will also receive an information booklet about fatigue that is freely available from the UK MS Society. This booklet provides general information about MS-related fatigue, strategies to self-monitor and self-manage symptoms, and directs them to contact health professionals involved in their care for support if required.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Multiple Sclerosis
Keywords
Multiple Sclerosis, Exercise, Fatigue

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
45 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Tailored exercise intervention
Arm Type
Experimental
Arm Description
8 weeks of aerobic interval training at moderate intensity which is modified according to the levels of self-reported fatigue
Arm Title
Standard exercise intervention
Arm Type
Active Comparator
Arm Description
8 weeks of aerobic interval training at a moderate intensity
Arm Title
Usual care control
Arm Type
No Intervention
Arm Description
Participants in the usual care control group will continue to receive their standard care independent of this study
Intervention Type
Other
Intervention Name(s)
Tailored exercise intervention
Intervention Description
2x 30 minute aerobic interval training per week for 8 weeks - sessions involve 6 intervals cycling for 2 minutes at target heart rate reserve followed by 2 minutes working rest (target heart rate reserve may vary between sessions depending on the level of self-reported fatigue)
Intervention Type
Other
Intervention Name(s)
Standard exercise intervention
Intervention Description
2x 30 minute aerobic interval training per week for 8 weeks - sessions involve 6 intervals cycling for 2 minutes at >70% heart rate reserve followed by 2 minutes working rest
Primary Outcome Measure Information:
Title
Intervention tolerance
Description
Participants will record the severity of fatigue before and for 48-hours following each exercise session using a Numerical Rating Scale
Time Frame
Weeks 1-8
Title
Intervention adherence
Description
Adherence will be determined by recording the proportion of exercise sessions that each participant attends, whether the participant completes the prescribed exercise duration during each session, and whether the participant is able to reach and maintain the prescribed target heart rate
Time Frame
Weeks 1-8
Title
Intervention acceptability
Description
The participants' views of the study procedures will be explored using an online survey. The survey contains questions relating to the content of the exercise/control groups, relevance of outcome measures included, the perceived positive/negatives of the intervention, and ways to improve the study design
Time Frame
Week 8
Secondary Outcome Measure Information:
Title
Fatigue Severity Scale
Description
Self-reported questionnaire measuring the severity of fatigue
Time Frame
Baseline, 8 weeks
Title
Modified Fatigue Impact Scale
Description
Self-reported questionnaire measuring the impact of fatigue on physical, cognitive, and psychosocial function
Time Frame
Baseline, 8 weeks
Title
Aerobic capacity
Description
Aerobic capacity estimated using the YMCA sub-maximal bicycle ergometer test
Time Frame
Baseline, 8 weeks
Title
Multiple Sclerosis Impact Scale
Description
Self-reported questionnaire measuring the physical and psychological impact of Multiple Sclerosis
Time Frame
Baseline, 8 weeks
Title
Hospital Anxiety and Depression Scale
Description
Self-reported questionnaire measuring the severity of anxiety and depression
Time Frame
Baseline, 8 weeks
Title
Pittsburgh Sleep Quality Index
Description
Self-reported questionnaire measuring sleep quality
Time Frame
Baseline, 8 weeks
Title
Symbol Digits Modalities Test
Description
Cognitive screening tool which measures processing speed
Time Frame
Baseline, 8 weeks
Title
Six Minute Walk Test
Description
Measurement of the maximum walking distance covered during 6 minutes
Time Frame
Baseline, 8 weeks
Title
Energy Cost of Walking
Description
Estimation of oxygen consumption per meter walked during the six minute walk test measured using Cosmed K4 portable oxygen telemetry system
Time Frame
Baseline, 8 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Neurologist-confirmed diagnosis of MS and a progressive form of the disease (either secondary or primary progressive) Self-report of moderate-severe fatigue in the last 7 days at screening by indicating that their fatigue is six or more when answering the following "have you had fatigue in the last seven days: between 0 (no fatigue) and 10 (extremely fatigued). Moderate level of disability to allow for participants to use the bicycle ergometer (indicated by an Expanded Disability Status Scale score of between ≥4 and ≤6.5) Be willing and able to attend Falkirk Community Hospital, twice a week for 8 consecutive weeks to receive the intervention. Exclusion Criteria: A neurologist confirmed relapse of MS within the past three months Commenced or had a change in MS disease modifying treatment within the past six months Unable to provide informed consent Concurrently participating in another intervention trial Diagnosed with any of the following conditions which may also cause high levels of fatigue: anaemia, inflammatory rheumatic disease, hypothyroidism, cancer Cardiovascular event in the past year including but not limited to: myocardial infarction, transient ischaemic attack or cerebrovascular accident Diagnosis of cardiovascular, respiratory, or metabolic disease that would prevent participants from safely performing exercise including but not limited to: angina, heart failure, uncontrolled hypertension, peripheral vascular disease, chronic obstructive pulmonary disease, diabetes mellitus Prescription of the following medication: beta blockers, vasodilators, ACE inhibitors, diuretics or any other medication that may cause exercise induced hypotension Significant co-morbidity such as significant musculoskeletal or neurological conditions other than MS
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Scott Rooney
Phone
0141 273 1695
Email
scott.rooney@gcu.ac.uk
First Name & Middle Initial & Last Name or Official Title & Degree
Lorna Paul
Phone
+44 1413318108
Email
Lorna.Paul@gcu.ac.uk
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Scott Rooney, PhD
Organizational Affiliation
Glasgow Caledonian University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Falkirk Community Hospital
City
Falkirk
ZIP/Postal Code
FK1 5QE
Country
United Kingdom
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Scott Rooney
Phone
0141 273 1695
Email
scott.rooney@gcu.ac.uk

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Exercise to Manage Fatigue in Progressive Multiple Sclerosis

We'll reach out to this number within 24 hrs